On August 27, 2026, an independent veterinary medical testing center completed a 1500-cycle continuous endurance verification for a newly developed mini orthopedic reduction forceps tailored for small animals. The test results show that after 1500 repeated clamping operations on 2mm-thick feline tibial bone specimens, the tip wear of this small animal orthopedic reduction forceps is only 0.012mm, and its clamping holding force remains above 98% of the initial value, marking a major breakthrough in the field of high-precision small animal orthopedic surgical instruments.

      This test is carried out in strict accordance with the international veterinary surgical instrument testing standards, simulating the high-intensity operation scenarios of small animal orthopedic surgery such as oblique fracture alignment and minimally invasive plate placement. The test data indicates that this small animal orthopedic reduction forceps adopts integral tungsten steel inlay technology on the clamping tip, with a special arc-shaped force-bearing design. Even when clamping ultra-fine pet bones with a diameter of less than 3mm, the stress can be evenly distributed around the bone tissue, completely avoiding the risk of iatrogenic bone crushing that frequently occurs with traditional ordinary reduction forceps. The participating veterinary orthopedic experts stated that this product can increase the one-time success rate of minimally invasive fracture reduction in cats and toy-breed dogs by 37%, and effectively reduce the operation difficulty for young veterinary surgeons.

      At present, the global number of registered small animal veterinary clinics has exceeded 450,000, and the penetration rate of orthopedic surgical services in primary clinics is rising rapidly. This newly verified small animal orthopedic reduction forceps has been selected as a designated training tool by 7 international veterinary orthopedic training institutions, and it will be officially launched in the European and North American markets in the second half of 2026. The product is expected to reduce the procurement cost of high-precision orthopedic instruments for primary companion animal hospitals by 55%.